Vitamin D and Respiratory Health: What the Evidence Supports
One of the few supplement questions where a blood test genuinely changes the answer.
Does vitamin D help respiratory health?
A systematic review and meta-analysis published in the BMJ examined vitamin D supplementation and acute respiratory tract infection, finding protective effects concentrated in participants who were deficient at baseline. Vitamin D receptors are present on immune cells and it influences antimicrobial peptide production. The practical implication is that correcting genuine deficiency matters, while supplementing sufficiency shows limited benefit.
Why vitamin D is a respiratory topic at all
Vitamin D functions more like a hormone than a conventional vitamin. Its receptor is expressed on cells throughout the body, including immune cells — macrophages, dendritic cells, T cells and B cells.
In respiratory immune function specifically, it influences production of antimicrobial peptides including cathelicidin and defensins, which are part of the innate defence at mucosal surfaces. It also modulates inflammatory response, which matters because airway damage in infection comes substantially from the immune response rather than the pathogen alone.
The biological plausibility is not the weak part of this story.
What the large analysis found
A systematic review and meta-analysis of individual participant data published in the BMJ examined vitamin D supplementation and acute respiratory tract infection.
The headline result showed a protective effect. The more informative detail was in the subgroup analysis: benefit was concentrated in participants with low baseline vitamin D levels, and dosing regimen mattered — regular daily or weekly dosing performed differently from large intermittent bolus doses.
This subgroup pattern is the single most useful thing to take from the vitamin D literature, and it generalises. Correcting a deficiency produces measurable benefit. Adding more to someone already sufficient generally does not.
Why deficiency is so common
Synthesis requires UVB exposure to skin, which is constrained by latitude, season, time spent indoors, clothing, sunscreen and skin pigmentation.
Above roughly 37 degrees latitude, winter sun angle is insufficient for meaningful synthesis for several months of the year. Older adults synthesise less efficiently from the same exposure. Darker skin requires longer exposure for equivalent synthesis. And most people now spend the overwhelming majority of daylight hours indoors.
Dietary sources are limited — oily fish, egg yolks, some fortified products — and rarely sufficient alone.
Vitamin D3 is one of six actives in BreathEaseX
Alongside NAC, manuka honey, quercetin, olive leaf extract and L-theanine.
Test rather than guess
This is the practical recommendation, and it is unusual in supplement discussion because it actually resolves the question.
A 25-hydroxyvitamin D blood test tells you whether you are deficient, insufficient or sufficient. If deficient, supplementation is likely to help and the appropriate dose can be chosen. If sufficient, expecting respiratory benefit from more is not supported by the trial data.
The test is inexpensive and widely available. Guessing is inefficient in both directions.
If you do supplement
- D3 (cholecalciferol) is generally preferred over D2 for raising and maintaining blood levels.
- Take it with a meal containing fat. Absorption is fat-dependent, and this materially affects how much you get.
- Daily or weekly beats large monthly boluses based on the dosing patterns in the meta-analysis.
- Retest after three months if you started because of documented deficiency.
- Do not megadose. Excessive intake causes hypercalcaemia, which is genuinely harmful. More is not better.
What it will not do
Vitamin D is not a treatment for respiratory infection and does not replace vaccination, medical care or prescribed therapy. The evidence concerns modest reduction in infection incidence in deficient populations, which is a narrower claim than much of the commentary around it suggests.
